TrademarkDir
TISSUECYPHER
LIVE

Serial Number

86221686

Owner

CASTLE BIOSCIENCES, INC.

Attorney

James D. Petruzzi

First Use Date

Jun 15, 2016

Filing Date

Mar 14, 2014

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TISSUECYPHER Trademark

Serial Number: 86221686 • Registration: 5078325

TISSUECYPHER is a trademark filed by CASTLE BIOSCIENCES, INC. on March 14, 2014. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CASTLE BIOSCIENCES, INC. (5 trademarks)

505 S. FRIENDSWOOD DRIVE
HOUSTON, TX 77546

Entity Type: 03

Cernostics, Inc.

Pittsburgh, PA 15238

Entity Type: 03

Trademark Details

Filing Date

March 14, 2014

Registration Date

November 8, 2016

First Use Anywhere

June 15, 2016

First Use in Commerce

June 15, 2016

Published for Opposition

August 11, 2015

Goods & Services

Medical testing for diagnostic purposes using an imaging platform in the field of tissue profiling

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Mar 19, 2026 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Mar 19, 2026 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Mar 19, 2026 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 19, 2026 APRE
TEAS SECTION 8 & 9 RECEIVED
Jan 5, 2026 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 8, 2025 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 20, 2024 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 10, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 10, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 10, 2023 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 31, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 8, 2021 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 2, 2019 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 21, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 21, 2016 REAP
REGISTERED-PRINCIPAL REGISTER
Nov 8, 2016 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 6, 2016 SUNA
SOU TEAS EXTENSION RECEIVED
Oct 5, 2016 EEXT
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 5, 2016 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 5, 2016 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 25, 2016 AITU
USE AMENDMENT FILED
Sep 6, 2016 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 6, 2016 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 5, 2016 EXRA
SOU EXTENSION 1 GRANTED
Apr 1, 2016 EX1G
SOU EXTENSION 1 FILED
Apr 1, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 1, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 6, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2015 NPUB
PUBLISHED FOR OPPOSITION
Aug 11, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 6, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 15, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2015 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 15, 2015 ERFR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 11, 2015 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 11, 2015 COAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 11, 2015 EWAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 12, 2015 GNFN
FINAL REFUSAL E-MAILED
Jan 12, 2015 GNFR
FINAL REFUSAL WRITTEN
Jan 12, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 31, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 31, 2014 CRFA
ASSIGNED TO LIE
Dec 31, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 17, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 18, 2014 GNRN
NON-FINAL ACTION E-MAILED
Jun 18, 2014 GNRT
NON-FINAL ACTION WRITTEN
Jun 18, 2014 CNRT
ASSIGNED TO EXAMINER
Jun 18, 2014 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Mar 29, 2014 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2014 NWOS
NEW APPLICATION ENTERED
Mar 18, 2014 NWAP

Related Trademarks

More from this Owner

IDGENETIX

IDGENETIX

IDGENETIX logo

IDGENETIX

MAKING PERSONALIZED MEDICINE POSSIBLE

MAKING PERSONALIZED MEDICINE POSSIBLE

MYPATH

MYPATH